Transition Therapeutics (Transition Therapeutics) Equity-to-Asset : 0.82 (As of Mar. 2016)

Transition Therapeutics Equity-to-Asset Chart

Transition Therapeutics Annual Data
	Trend	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15
Equity-to-Asset		Get a 7-Day Free Trial					0.89	0.87	0.88	0.86	0.74

Transition Therapeutics Quarterly Data
	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16
Equity-to-Asset	Get a 7-Day Free Trial															0.83	0.74	0.80	0.82	0.82

Competitive Comparison of Transition Therapeutics's Equity-to-Asset

For the Biotechnology subindustry, Transition Therapeutics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transition Therapeutics's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transition Therapeutics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Transition Therapeutics's Equity-to-Asset falls into.

Transition Therapeutics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Transition Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Jun. 2015 is calculated as

Transition Therapeutics's Equity to Asset Ratio for the quarter that ended in Mar. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transition Therapeutics  (NAS:TTHI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Transition Therapeutics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Transition Therapeutics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Transition Therapeutics (Transition Therapeutics) Business Description